Stephen Crohn, Who Furthered AIDS Study, Dies at 66

September 25, 2013 | Alumni

By JOHN SCHWARTZ

September 15, 2013

His boyfriend was dying of a disease without a name.

Beginning in 1978, Stephen Crohn cared for Jerry Green, a handsome gymnast, as he lost 30 pounds, went blind and was ravaged by the kinds of infections that rarely harmed otherwise healthy people.

Mr. Green was one of the first people to die of the disease that became known as AIDS. In the ensuing years, scores of Mr. Crohn’s friends died of it. He had taken no special precautions, and he had been as sexually active as his friends.

But he never got sick.

Mr. Crohn’s resistance helped lead to a deeper understanding of H.I.V., the virus that causes AIDS, simply by staying alive and working with doctors to help figure out why he was.

“What he contributed to medical knowledge is really quite extraordinary,” said Dr. Bruce D. Walker, the director of the Ragon Institute of Massachusetts General Hospital, M.I.T. and Harvard.

Mr. Crohn died on Aug. 23 in New York City at 66. The cause was suicide, his sister Amy Crohn Santagata said on Friday in confirming the death, which was not announced at the time.

Mr. Crohn’s immune system and its quirks earned him unsought renown. In 1996, the British newspaper The Independent called him “The Man Who Can’t Catch AIDS,” and he told his story in documentary films and newspaper interviews around the world.

Mr. Crohn had first come to the attention of Dr. Bill Paxton, then a scientist at the Aaron Diamond AIDS Research Center in New York. Dr. Paxton had been looking for gay men who seemed resistant to infection. Working with Dr. David Ho, now the chief executive of the Diamond Center, Dr. Paxton exposed Mr. Crohn’s cells, and those of another promising volunteer, to H.I.V.

“I couldn’t infect the CD4 cells,” he said in an interview. “I’d never seen that before.”

The CD4 white blood cells, which H.I.V. normally penetrates to start the process of disease, locked out the virus. Even at H.I.V. concentrations thousands of times greater than would be encountered outside a test tube, nothing happened.

Years later, researchers isolated the cause. H.I.V. gets into cells by fitting into two receptors on CD4 cells. But thanks to a genetic defect, the second receptor on Mr. Crohn’s CD4 cells was flawed. The malfunctioning receptor, CCR5, had no negative effect on his health and kept H.I.V. from getting in. As he put it in a “Nova” documentary on PBS: “It’s like a key — the virus comes with this. It’s looking for a two-holed keyhole. I don’t have one of the holes. Period. It’s never going to attach to me.”

The genetic anomaly, known as the delta 32 mutation, which produces the flawed receptor, is found in less than 1 percent of the population.

Stephen Lyon Crohn was born on Sept. 5, 1946, in Manhattan to Richard Crohn (who also had the gene) and the former Janet Goren. He was raised in Dumont, N.J., and was educated at New York University, City College of New York and the Art Students League of New York. He lived in Saugerties, N.Y.

Besides Ms. Santagata, Mr. Crohn is survived by two other sisters, Carla Crohn Friedman and Judith Bloom, as well as many nieces and nephews.

Mr. Crohn was an artist and worked as a freelance editor for Fodor’s Travel. His paintings, mainly abstract works that evoked landscapes, were exhibited in New York, San Francisco and elsewhere.

“My brother saw all his friends around him dying, and he didn’t die,” Ms. Santagata said. “He went through a tremendous amount of survivor guilt about that and said to himself, ‘There’s got to be a reason.’ ”

“He was quite extraordinary, and then also quite ordinary,” she said.

Mr. Crohn was the great-nephew of Burrill B. Crohn, a leading gastroenterologist who first described the disease that carries his name.

Mr. Crohn felt he was carrying on “his family’s tradition” by helping researchers, said Dr. Paxton, now a professor of infection and immunity at the University of Liverpool Institute of Infection and Global Health.

The research based on Mr. Crohn’s immune system has led to advances in fighting H.I.V.

A drug that blocks the CCR5 receptor, maraviroc, is now used to keep infection from spreading in patients who have contracted the virus. And in 2006, an AIDS patient in Berlin was effectively cured of the disease after receiving bone marrow transplants from a matching donor who had the delta 32 mutation.

“This is a classic case of medical science learning from patients,” said Dr. Walker of the Ragon Institute. “Most of the immunology we know comes from studying other animal models,” he said. “We need to study humans who have real diseases.”

He explained, “You take the extreme examples and try to see how those people are different from the average person with the disease.”

So, he said, Dr. Paxton and colleagues asked, “How is Steve different from the average person with H.I.V. infection? And bingo, they found it.”

Dr. Paxton and Mr. Crohn remained friends. “He was the type of guy who walks into the room, and it lights up,” he said. “I was going to call him this weekend.”

Originally published by The New York Times